Delivering quality therapy through generations
Search
 
  • Magyar
  • Русский
  • GR worldwide:
Skip Navigation Links
Printable version
Gynaecological portfolio has widened significantly during the past few decades 
Gynaecological portfolio has widened significantly during the past few decades 
Gynaecology 
The manufacturing of products for preserving women’s reproductive health goes back to the Company’s foundation in 1901. Gynaecological portfolio has widened significantly during the past few decades, offering not only advanced contraceptives and emergency contraception products but hormone replacement preparations (including two patches), treatments for gynaecological infections and other products.
It was in 1967 that Richter launched in Hungary the contraceptive pill used in everyday medical practice. The method was revolutionary since it brought changes in the field of family planning, sexual behaviour and sociology. Thanks to our research and development activity, Richter contraceptive pills contain very low hormone doses, 1-3% of the original dose.

Despite the reduced hormone dose, the tablets have preserved their contraceptive efficiency. Moreover, with negative side-effects and potential risks minimised, product safety has significantly increased.

Contraceptive pills exhibit a number of important preventive effects and therapeutic actions. These include a positive influence on abnormal menstrual bleeding and premenstrual or mid-cycle discomfort, prevention against iron deficiency anaemia, the development of pelvic inflammatory diseases and ovarian cancer as well as a less frequent occurrence of benign breast and womb tumors. Naturally, hormonal contraception, similar to the administration of any preparation, is not risk-free. However, the incidence of potential complications is eclipsed by the risks associated with pregnancy, childbirth and childbed or the termination of pregnancy. As of today Gedeon Richter is the leader in the Hungarian contraceptive market.

Abortion is a problem of special importance both from the aspect of population policy and that of health care. The primary goal is to reduce the number of unintended pregnancies. In case there is a risk of unintended pregnancy because of nouse or misuse of contraception, emergency contraception may provide a solution.

Vaginal fungal infection is soon becoming an epidemic. 75% of women confront the disease at least once in their lifetime while half of them have to fight the infection on more than one occasion. With one in twenty women vaginal fungal infection is recurrent, that is it occurs four or more times per year, resulting in considerable deterioration in the patients’ quality of life. Our advanced systemic and local antifungal preparations offer an easily available treatment for patients suffering from acute and chronic recurrent vaginal fungal infection.

Demographic statistics show that the average life expectancy has significantly increased. One consequence is that there is greater number of women reaching menopause. The climacteric is not a disease but a natural process which occurs in and is an integral part of every woman’s life. Menopause is one of the most important events in this period, it is defined as the last menstrual period which is not repeated by another in the successive year. Women experience many uncomfortable symptoms during this phase, which can be alleviated by Richter’s hormone replacement therapy products. Menopausal hormone therapy preparations relieve hot flushes and night-time sweating, sleeping disorders and mood changes associated with the climacteric.

PRICE BOX
BSE 2010.03.12. 01:48
42 000 HUF - 0.48%